Vantive Health Llc

This study tests a device called PrismaLung+ that removes carbon dioxide from the blood of critically ill patients who are on breathing machines. The trial will include 99 adults with acute respiratory distress syndrome or kidney injury. Half will receive standard care plus the d…

This phase 3 trial is testing Prismocitrate 18, a special fluid used during continuous kidney dialysis to prevent blood clots in the dialysis machine. The study will enroll 40 adults with acute kidney injury who need dialysis and cannot use standard blood thinners. Researchers wi…

This study follows adults with end-stage renal disease who are starting dialysis to compare three approaches: automated peritoneal dialysis with remote monitoring, manual peritoneal dialysis, and in-center hemodialysis. Researchers will track quality of life, social reintegration…